Press Releases

Press Releases

The 4th Annual Cell Culture & Bioprocessing Congress is taking place on the 9th & 10th of November 2015 in London, UK. The congress brings together over 170 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. The two day congress will cover topics within Cell…

Press Releases

Chugai Pharmaceutical Co., Ltd. and Taisho Pharmaceutical Co., Ltd., announced today that the positive results of Japanese phase III clinical trial (The MOVEST study: Monthly Oral VErsus intravenouS ibandronaTe) of a bisphosphonate antiresorptive agent, ibandronate sodium hydrate oral agent (Chugai Development Code: RG484, Taisho Development Code: CT-064, hereafter, "ibandronate oral…

Press Releases

Camurus AB (“Camurus”) and Solasia Pharma K.K. (“Solasia”) jointly announced today that they have entered into a license and distribution agreement for episil® oral liquid, a unique and effective treatment for the pain of oral mucositis, a treatment-limiting side effect of some cancer therapies, as well as other oral lesions.…

Press Releases

RXi Pharmaceuticals Corporation and privately-held MirImmune LLC, today announced that they have entered into an exclusive license agreement to RXi's novel and proprietary sd-rxRNA® technology for use in developing innovative cell-based cancer immunotherapies. The collaboration has the potential to result in novel, more effective and patient friendly cancer treatments that…

Press Releases

IFC, a member of the World Bank Group, today announced a loan of $4.5 million to Goodlife Pharmacy Limited to help the company open a chain of 80 pharmacies across Kenya and East Africa. Goodlife will supply affordable, quality healthcare products in Kenya, where there are few nationwide chains, and…

Press Releases

Shanghai Pharmaceuticals Holding Co. Ltd.,together with its subsidiaries,stock code: 601607.SH; 02607.HK),announced its annual results for the year ended 31 December 2015 (the “reporting period”). According to the report, under the ''new normal'' of the slowdown of the overall revenue and profit growth resulted from numerous factors such as the decelerated…

Press Releases

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).  In 2014, the FDA granted EYLEA Breakthrough Therapy designation and Priority Review for the treatment of diabetic retinopathy in…

Press Releases

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on developing breakthrough treatments for human disease, today announced that it has commenced screening in its first pivotal Phase 3 clinical trial of sotagliflozin for type 1 diabetes. "We are pleased to achieve this important milestone in sotagliflozin's Phase 3 development on schedule,"…

Press Releases

RnRMarketResearch.com adds "Rectal Cancer - Pipeline Review, H1 2015" therapeutic market research report of 106 pages with latest updates, data and information to its online business intelligence library. The report "Rectal Cancer - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Rectal Cancer, complete with comparative…

Press Releases

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced its plans for the commercialization of SPRIX (ketorolac tromethamine) Nasal Spray and OXAYDO (oxycodone HCI, USP) tablets for oral use only –CII. SPRIX is a non-steroidal anti-inflammatory drug (NSAID) indicated in…